Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 29, 2023

Study Completion Date

December 29, 2023

Conditions
Type 1 Diabetes
Interventions
DEVICE

Insulin Pump with Continuous Glucose Monitoring

MiniMed™ 780G insulin pump in combination with the DS5 CGM

Trial Locations (23)

11042

Northwell Health for Cohen Children's Medical Center of New York, New Hyde Park

11501

New York University (NYU) Langone Hospital Long Island, Mineola

19104

Children's Hospital of Philadelphia, Philadelphia

30076

Endocrine Research Solutions, Roswell

30318

Atlanta Diabetes Associates, Atlanta

33612

University of South Florida (USF) Diabetes Center, Tampa

38133

AM Diabetes and Endocrinology Center, Bartlett

44106

University Hospitals Rainbow Babies & Childrens Hospital, Cleveland

55102

Childrens Hospital and Clinics of Minnesota, Saint Paul

55416

Park Nicollet International Diabetes Center, Saint Louis Park

72211

Medical Investigations, Little Rock

78681

Texas Diabetes and Endocrinology, Round Rock

80045

Barbara Davis Center for Childhood Diabetes, Aurora

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

93105

Sansum Diabetes Research Institute, Santa Barbara

94158

University of California San Francisco (UCSF) The Madison Clinic for Pediatric Diabetes, San Francisco

94304

Stanford University, Palo Alto

94598

Diablo Clinical Research, Walnut Creek

98057

Rainier Clinical Research Center, Renton

98105

Seattle Childrens Hospital, Seattle

98405

Multicare Institute for Research and Innovation, Tacoma

06511

Yale School of Medicine, New Haven

02215

Joslin Diabetes Center, Boston

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY